Nucleus Of The Vertical Limb Of The Diagonal Band (Vdb) Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Nucleus of the Vertical Limb of the Diagonal Band (VDB) is a key cholinergic nucleus in the basal forebrain that plays crucial roles in memory, attention, and cortical arousal. It is one of the primary sources of cholinergic innervation to the hippocampus and olfactory bulb.
| Property | Value |
|---|---|
| Cell Type | Cholinergic neurons |
| Location | Basal forebrain, vertical limb of diagonal band of Broca |
| Neurotransmitter | Acetylcholine (ACh) |
| Marker Genes | CHAT, ACHE, SLC18A3 (VAChT), NGFR (p75^NTR) |
| Brain Regions Innervated | Hippocampus, Olfactory bulb, Entorhinal cortex |
| Associated Diseases | Alzheimer's Disease, Schizophrenia, Depression |
VDB cholinergic neurons are large multipolar neurons with extensive dendritic arborizations. They express:
These neurons are morphologically similar to other basal forebrain cholinergic neurons (NBM, MS) but have distinct projection patterns targeting the hippocampal formation and olfactory bulb.
VDB cholinergic neurons project heavily to the hippocampal formation, particularly the dentate gyrus and CA1 region. Acetylcholine release facilitates:
VDB provides the primary cholinergic input to the olfactory bulb, modulating:
As part of the basal forebrain arousal system, VDB neurons contribute to:
VDB neurons show early and severe degeneration in AD:
Key differentially expressed genes in VDB cholinergic neurons include:
| Gene | Expression | Function |
|---|---|---|
| CHAT | High | Acetylcholine synthesis |
| SLC18A3 | High | Vesicular ACh transport |
| NGFR | High | Neurotrophin receptor |
| NTRK1 | Moderate | NGF signaling |
| BDNF | Moderate | Neurotrophin support |
| SYN1 | High | Synaptic vesicle function |
| MAPT | Moderate | Tau protein |
The study of Nucleus Of The Vertical Limb Of The Diagonal Band (Vdb) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Mesulam MM, Mufson EJ, Levey AI, Wainer BH. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol. 1983.
[2] Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science. 1982.
[3] Schliebs R, Arendt T. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm. 2006.
[4] Hampel H, Mesulam MM, Cuello AC, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. Brain. 2019.
[5] Haam J, Yakel JL. Cholinergic modulation of hippocampal cellular functions. Curr Top Behav Neurosci. 2017.
[6] Everitt BJ, Robbins TW. Central cholinergic systems and cognition. Annu Rev Psychol. 1997.
[7] Fibiger HC. Cholinergic mechanisms in learning, memory and dementia. Prog Neuropsychopharmacol Biol Psychiatry. 1991.
[8] Wenk GL. The nucleus basalis magnocellularis cholinergic system: one hundred years of progress. Neurobiol Learn Mem. 1997.